Credits Available: 4.25 AMA PRA Category 1 Credits™, 4.25 ANCC Contact Hours, 4.25 ACPE

Description: This dynamic curriculum, detailed by a specialty center clinician, explores each of the CD 19-directed CAR T-cell therapies available for the treatment of DLBCL; solutions to referral and logistic challenges; in-depth early and late toxicity management in CAR T-cell treatment; and the delivery of goal-concordant care using shared decision-making strategies. A challenging real-world case scenario discussion within each Gather-ed group highlights critical decision points, key challenges, and opportunities to incorporate collective insights.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse Practitioner, Pharmacist, Physician Assistant, Nurse, Pharmacy Director
Target Specialties: Hematology, Hematology/Oncology, Oncology

Brandon Chang

Kaiser Permanente
Pharmacist-in-Charge

Dr. Brandon Chang is a Board-certified Oncology Pharmacist and the Pharmacist-in-Charge at Kaiser Permanente Bellflower Oncology Pharmacy. He received his Doctor of Pharmacy degree from the University of Southern California (USC) and then completed a PGY1 and PGY2 Residency. He is passionate about precepting and serves as the primary preceptor in oncology at Kaiser Permanente Downey Medical Center for pharmacy residents and students. His main clinical interests include thoracic oncology, immunotherapy, oncology, and supportive care.